In last trading session, Praxis Precision Medicines Inc (NASDAQ:PRAX) saw 0.61 million shares changing hands with its beta currently measuring 2.63. Company’s recent per share price level of $43.0 trading at -$1.04 or -2.36% at ring of the bell on the day assigns it a market valuation of $875.87M. That closing price of PRAX’s stock is at a discount of -113.56% from its 52-week high price of $91.83 and is indicating a premium of 37.91% from its 52-week low price of $26.70. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.26 million shares which gives us an average trading volume of 398.88K if we extend that period to 3-months.
For Praxis Precision Medicines Inc (PRAX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.42. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 4 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Praxis Precision Medicines Inc (NASDAQ:PRAX) trade information
Upright in the red during last session for losing -2.36%, in the last five days PRAX remained trading in the green while hitting it’s week-highest on Friday, 06/27/25 when the stock touched $43.0 price level, adding 3.15% to its value on the day. Praxis Precision Medicines Inc’s shares saw a change of 12.98% in year-to-date performance and have moved 1.56% in past 5-day. Praxis Precision Medicines Inc (NASDAQ:PRAX) showed a performance of 16.12% in past 30-days. Number of shares sold short was 1.74 million shares which calculate 5.78 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 85 to the stock, which implies a rise of 49.41% to its current value. Analysts have been projecting 73 as a low price target for the stock while placing it at a high target of 120. It follows that stock’s current price would drop -69.77% in reaching the projected high whereas dropping to the targeted low would mean a loss of -69.77% for stock’s current value.
Praxis Precision Medicines Inc (PRAX) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 8.54% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -23.76% while estimates for its earnings growth in next 5 years are of -2.34%.
Praxis Precision Medicines Inc (NASDAQ:PRAX)’s Major holders
Insiders are in possession of 0.16% of company’s total shares while institution are holding 122.01 percent of that, with stock having share float percentage of 122.20%. Investors also watch the number of corporate investors in a company very closely, which is 122.01% institutions for Praxis Precision Medicines Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at PRAX for having 1.29 million shares of worth $53.52 million. And as of 2024-06-30, it was holding 6.874 of the company’s outstanding shares.
The second largest institutional holder is RA CAPITAL MANAGEMENT, L.P., which was holding about 1.24 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.5638 of outstanding shares, having a total worth of $51.1 million.
On the other hand, SMALLCAP WORLD FUND INC and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 748.24 shares of worth $32.17 million or 3.67% of the total outstanding shares. The later fund manager was in possession of 562.19 shares on Mar 31, 2025 , making its stake of worth around $24.17 million in the company or a holder of 2.76% of company’s stock.
